| 000 | 01529 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517045424.0 | ||
| 264 | 0 | _c20160520 | |
| 008 | 201605s 0 0 eng d | ||
| 022 | _a1545-9616 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSorensen, Eric P | |
| 245 | 0 | 0 |
_aTumor Necrosis Factor Inhibitor Primary Failure Predicts Decreased Ustekinumab Efficacy in Psoriasis Patients. _h[electronic resource] |
| 260 |
_bJournal of drugs in dermatology : JDD _cAug 2015 |
||
| 300 |
_a893-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdalimumab _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aDermatologic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aEtanercept _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfliximab _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
| 650 | 0 | 4 | _aRetreatment |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Failure |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aUstekinumab _xtherapeutic use |
| 700 | 1 | _aFanucci, Kristina A | |
| 700 | 1 | _aSaraiya, Ami | |
| 700 | 1 | _aVolf, Eva | |
| 700 | 1 | _aAu, Shiu-chung | |
| 700 | 1 | _aArgobi, Yahya | |
| 700 | 1 | _aMansfield, Ryan | |
| 700 | 1 | _aGottlieb, Alice B | |
| 773 | 0 |
_tJournal of drugs in dermatology : JDD _gvol. 14 _gno. 8 _gp. 893-8 |
|
| 999 |
_c25163901 _d25163901 |
||